Trevi Therapeutics, Inc. - Common Stock (TRVI)
CUSIP: 89532M101
Q2 2024 13F Holders as of 30 Jun 2024
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 128,120,714
- Total 13F shares
- 55,906,669
- Share change
- +4,307,832
- Total reported value
- $166,602,895
- Put/Call ratio
- 0%
- Price per share
- $2.98
- Number of holders
- 76
- Value change
- +$12,771,260
- Number of buys
- 40
- Number of sells
- 23
Quarterly Holders Quick Answers
What is CUSIP 89532M101?
CUSIP 89532M101 identifies TRVI - Trevi Therapeutics, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 89532M101:
Top shareholders of TRVI - Trevi Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| NEA Management Company, LLC |
13F
|
Company |
8.9%
|
11,370,376
|
$39,227,798 | — | 31 Mar 2024 | |
| Frazier Life Sciences Management, L.P. |
13F
|
Company |
5.8%
|
7,381,090
|
$25,464,761 | — | 31 Mar 2024 | |
| Rubric Capital Management LP |
13F
|
Company |
4.3%
|
5,564,123
|
$19,196,224 | — | 31 Mar 2024 | |
| VIKING GLOBAL INVESTORS LP |
13F
|
Company |
3.4%
|
4,400,000
|
$15,180,000 | — | 31 Mar 2024 | |
| VR Adviser, LLC |
13F
|
Company |
2.7%
|
3,422,675
|
$11,808,229 | — | 31 Mar 2024 | |
| Opaleye Management Inc. |
13F
|
Company |
2.1%
|
2,645,000
|
$9,125,250 | — | 31 Mar 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
1.9%
|
2,375,709
|
$8,196,196 | — | 31 Mar 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.8%
|
2,303,648
|
$7,947,586 | — | 31 Mar 2024 | |
| TPG GP A, LLC |
3/4/5
|
Former 10% Owner |
—
class O/S missing
|
3,824,883
|
$7,726,264 | — | 01 Jul 2022 | |
| Logos Global Management LP |
13F
|
Company |
1.7%
|
2,200,000
|
$7,590,000 | — | 31 Mar 2024 | |
| MPM BioImpact LLC |
13F
|
Company |
1%
|
1,340,960
|
$4,626,312 | — | 31 Mar 2024 | |
| MAI Capital Management |
13F
|
Company |
0.88%
|
1,131,821
|
$3,904,782 | — | 31 Mar 2024 | |
| Rosalind Advisors, Inc. |
13F
|
Company |
0.72%
|
926,016
|
$3,194,755 | — | 31 Mar 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.7%
|
897,965
|
$3,098,325 | — | 31 Mar 2024 | |
| SILVERARC CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.66%
|
844,235
|
$2,912,611 | — | 31 Mar 2024 | |
| STATE STREET CORP |
13F
|
Company |
0.62%
|
798,249
|
$2,753,959 | — | 31 Mar 2024 | |
| LANDSCAPE CAPITAL MANAGEMENT, L.L.C. |
13F
|
Company |
0.58%
|
740,128
|
$2,553,442 | — | 31 Mar 2024 | |
| Peter W. Sonsini |
3/4/5
|
10%+ Owner |
—
mixed-class rows
|
3,948,948
mixed-class rows
|
$1,916,875 | — | 11 Apr 2022 | |
| Checkpoint Capital L.P. |
13F
|
Company |
0.4%
|
506,082
|
$1,745,983 | — | 31 Mar 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.26%
|
327,692
|
$1,130,537 | — | 31 Mar 2024 | |
| Propel Bio Management, LLC |
13F
|
Company |
0.2%
|
260,000
|
$897,000 | — | 31 Mar 2024 | |
| Simplify Asset Management Inc. |
13F
|
Company |
0.16%
|
200,000
|
$690,000 | — | 31 Mar 2024 | |
| J. Goldman & Co LP |
13F
|
Company |
0.11%
|
137,873
|
$475,662 | — | 31 Mar 2024 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.1%
|
128,627
|
$443,763 | — | 31 Mar 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.09%
|
116,842
|
$403,000 | — | 31 Mar 2024 | |
| Shay Capital LLC |
13F
|
Company |
0.09%
|
113,662
|
$392,134 | — | 31 Mar 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.08%
|
107,707
|
$371,589 | — | 31 Mar 2024 | |
| PFS Partners, LLC |
13F
|
Company |
0.08%
|
99,000
|
$341,550 | — | 31 Mar 2024 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.08%
|
96,481
|
$332,859 | — | 31 Mar 2024 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.06%
|
74,849
|
$258,229 | — | 31 Mar 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0.05%
|
68,227
|
$235,382 | — | 31 Mar 2024 | |
| WealthTrust Axiom LLC |
13F
|
Company |
0.05%
|
63,500
|
$219,075 | — | 31 Mar 2024 | |
| OPPENHEIMER & CO INC |
13F
|
Company |
0.05%
|
60,415
|
$208,432 | — | 31 Mar 2024 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.04%
|
51,955
|
$179,238 | — | 31 Mar 2024 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.04%
|
46,206
|
$159,411 | — | 31 Mar 2024 | |
| Atom Investors LP |
13F
|
Company |
0.04%
|
45,736
|
$157,789 | — | 31 Mar 2024 | |
| UBS Group AG |
13F
|
Company |
0.03%
|
42,118
|
$145,307 | — | 31 Mar 2024 | |
| BAILARD, INC. |
13F
|
Company |
0.03%
|
40,900
|
$141,105 | — | 31 Mar 2024 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.03%
|
37,974
|
$131,010 | — | 31 Mar 2024 | |
| Tejara Capital Ltd |
13F
|
Company |
0.03%
|
37,481
|
$129,309 | — | 31 Mar 2024 | |
| TRUST CO OF TOLEDO NA /OH/ |
13F
|
Company |
0.03%
|
36,502
|
$125,932 | — | 31 Mar 2024 | |
| LPL Financial LLC |
13F
|
Company |
0.03%
|
36,000
|
$124,200 | — | 31 Mar 2024 | |
| BARCLAYS PLC |
13F
|
Company |
0.03%
|
35,195
|
$121,423 | — | 31 Mar 2024 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.02%
|
28,680
|
$98,946 | — | 31 Mar 2024 | |
| UNITED BANK |
13F
|
Company |
0.02%
|
28,450
|
$98,153 | — | 31 Mar 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.02%
|
25,463
|
$87,848 | — | 31 Mar 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.02%
|
22,735
|
$78,436 | — | 31 Mar 2024 | |
| MetLife Investment Management, LLC |
13F
|
Company |
0.02%
|
22,693
|
$78,291 | — | 31 Mar 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.02%
|
21,976
|
$75,817 | — | 31 Mar 2024 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.02%
|
21,608
|
$74,547 | — | 31 Mar 2024 |
Institutional Holders of Trevi Therapeutics, Inc. - Common Stock (TRVI) as of Q2 2024
As of 30 Jun 2024,
Trevi Therapeutics, Inc. - Common Stock (TRVI) was held by
76 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
55,906,669 shares.
The largest 10 holders included
NEA Management Company, LLC, Frazier Life Sciences Management, L.P., Rubric Capital Management LP, VIKING GLOBAL INVESTORS LP, VR Adviser, LLC, BlackRock Inc., Logos Global Management LP, Opaleye Management Inc., VANGUARD GROUP INC, and MPM BIOIMPACT LLC.
This page lists
76
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2024 vs Q1 2024 Across Filers
Q1 2024 holders
79
Q2 2024 holders
76
Holder diff
-3
| Investor | Q1 2024 Shares | Q2 2024 Shares | Share Diff | Share Chg % | Q1 2024 Value $ | Q2 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.